Is Humana’s (HUM) Mail-Order Expansion Quietly Redefining Its Integrated Care Advantage?
Truist Securities Maintains Hold on Humana, Raises Price Target to $320
Humana FY2026 Preliminary Adj EPS expected to be more than $9.00 vs $8.72 Est
Humana completes $83 million Florida infrastructure investment to deepen coordinated patient care approach
Humana (HUM) Slid as Medicare Advantage Rate Fell Short of Expectations
1 Momentum Stock on Our Buy List and 2 We Question
Humana (HUM) Valuation Check As Barostim Medicare Advantage Coverage Expands For Heart Failure Patients
Humana (HUM) is Rebounding to a Multi-Year Improvement in Margins and Returns
Agilon Health (AGL) Appoints Tim O’Rourke as Chief Executive Officer
Deutsche Bank Upgrades Humana (HUM)
Humana Just Got a Massive Upgrade From Deutsche Bank: Price Target Nearly Doubles to $441
Mizuho Maintains Outperform on Humana, Raises Price Target to $335
Deutsche Bank Upgrades Humana to Buy, Raises Price Target to $441
Here's Why Investors Should Stay Neutral on Humana Stock for Now
Many Retirees Find That Medicare Falls Short
RxBenefits Names Tim Kessler President to Advance Client Advocacy, Technology, and AI Innovation
Humana Expands Barostim Coverage What It Could Mean For Valuation
Humana Stock Outlook: Is Wall Street Bullish or Bearish?
Morgan Stanley Maintains Underweight on Humana, Raises Price Target to $217
2 Reasons to Watch HUM and 1 to Stay Cautious
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.